Analyst Reco. Centogene N.V.

Equities

CNTG

NL0014040206

Market Closed - Nasdaq Other stock markets 04:30:00 2024-05-01 pm EDT			5-day change	1st Jan Change
0.44 ^USD	+4.76%		-4.56%	-63.33%

Apr. 02	Centogene Gets Nasdaq Noncompliance Notice	MT
Mar. 19	Centogene, Takeda Pharmaceutical Collaborate on Lysosomal Storage Disorders Diagnostics	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

HC Wainwright Trims Price Target on Centogene to $1.50 From $2.50, Keeps Buy Rating	23-05-18	MT
HC Wainwright Reiterates Centogene N.V at Buy With $2.50 Price Target	23-01-17	MT
HC Wainwright Starts Centogene at Buy With $2.50 Price Target	22-11-23	MT
SVB Securities Adjusts Centogene's Price Target to $6 from $10, Keeps Outperform Rating	22-07-18	MT
Kempen Downgrades Centogene N.V to Neutral From Buy, Adjusts Target Price to $5.50 From $22	21-12-22	MT
BTIG Adjusts Centogene's Price Target to $18 From $23, Reiterates Buy Rating	21-12-16	MT
CENTOGENE N : Baird Adjusts Centogene's Price Target to $15 from $17, Keeps Outperform Rating	21-09-08	MT
CENTOGENE N : Credit Suisse Lowers Centogene's PT to $14 from $15 After Weaker-than-Expected Q1 Profitability, Keeps Outperform Rating	21-06-17	MT
CENTOGENE N : Credit Suisse Starts Centogene at Outperform with $15 Price Target	20-11-05	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+201.5% on SUPER MICRO COMPUTER since our purchase on February 17, 2023

Replicate our performance

fermer